Stay updated on Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.

Latest updates to the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page
- Check7 days agoChange DetectedA new page revision tag v3.6.6 has been added, replacing the previous v3.6.5. This reflects an updated version of the page rather than visible content changes.SummaryDifference0.0%

- Check14 days agoChange DetectedAdded the funding annotation '2018 ( U.S. NIH Grant/Contract )' in the study IDs section. This indicates NIH funding for the trial and clarifies its grant/contract source.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe revision tag on the page was updated from v3.6.4 to v3.6.5, indicating a newer build of the site's interface. This change appears to be a backend/UI update rather than a modification to the study content, eligibility criteria, or results.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, signaling a newer revision of the page content.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated to v3.6.3, replacing the previous v3.6.2 in the page's revision history.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a small update to the page's underlying build or documentation. This update does not alter visible content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.